VERVA PHARMACEUTICALS
Verva Pharmaceuticals Ltd. (“Verva”) was formed in December, 2007 by consolidation of key diabetes assets, discovery technologies and targets resident in Autogen Research Ltd. (formerly the diabetes-focused subsidiary of ChemGenex Pharmaceuticals) with those of obesity drug development company Adipogen Pharmaceuticals Pty Ltd. The combined product portfolio, technologies and expertise provide a substantial opportunity for rapid clinical progress and growth in high-value markets with a signif... icant unmet medical need. Verva operates in a completely virtual mode, managed by a CEO and Directors with extensive international product development and partnering experience. Verva’s founding research was undertaken at the Metabolic Research Unit of Deakin University in Geelong, Australia; a state-of-the-art facility providing access to key in vitro and in vivo models and capabilities. Verva has subsequently engaged expert scientists, clinicians, technical advisers and contract research organisations worldwide to implement the Company’s research and development strategy.
VERVA PHARMACEUTICALS
Social Links:
Industry:
Biotechnology Health Care Personal Health
Founded:
2007-01-01
Address:
Southbank, Victoria, Australia
Country:
Australia
Website Url:
http://www.vervapharma.com
Total Employee:
1+
Status:
Active
Contact:
61 4 4887 1479
Email Addresses:
[email protected]
Total Funding:
4.5 M AUD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Amazon Nginx DoubleClick.Net CloudFront Google Adsense AdBlock Acceptable Ads Google Adsense For Domains Amazon Ireland Region
Similar Organizations
Cerebral Therapeutics
Cerebral Therapeutics is a clinical-stage pharmaceutical company.
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
Akashi Therapeutics
Akashi Therapeutics is a clinical stage biopharmaceutical company.
Current Advisors List
Investors List
Medical Research Commercialisation Fund (MRCF)
Medical Research Commercialisation Fund (MRCF) investment in Venture Round - Verva Pharmaceuticals
Uniseed
Uniseed investment in Venture Round - Verva Pharmaceuticals
GBS Ventures
GBS Ventures investment in Venture Round - Verva Pharmaceuticals
QIC BioVentures
QIC BioVentures investment in Venture Round - Verva Pharmaceuticals
Uniseed
Uniseed investment in Venture Round - Verva Pharmaceuticals
GBS Ventures
GBS Ventures investment in Venture Round - Verva Pharmaceuticals
QIC BioVentures
QIC BioVentures investment in Venture Round - Verva Pharmaceuticals
Westscheme Pty Limited
Westscheme Pty Limited investment in Venture Round - Verva Pharmaceuticals
Official Site Inspections
http://www.vervapharma.com
- Host name: ec2-34-216-117-25.us-west-2.compute.amazonaws.com
- IP address: 34.216.117.25
- Location: Boardman United States
- Latitude: 45.8491
- Longitude: -119.7143
- Metro Code: 810
- Timezone: America/Los_Angeles
- Postal: 97818
More informations about "Verva Pharmaceuticals"
Verva Pharmaceuticals - Crunchbase Company Profile & Funding
Verva Pharmaceuticals Ltd. (“Verva”) was formed in December, 2007 by consolidation of key diabetes assets, discovery technologies and targets resident in Autogen Research Ltd. …See details»
Verva Pharmaceuticals - Products, Competitors, Financials, …
Verva Pharmaceuticals is an exciting, clinical-stage pharmaceutical company focused on the discovery and development of therapies to treat metabolic diseases (formerly Adipogen). Use …See details»
Verva Pharma - 2025 Company Profile - Tracxn
Apr 28, 2025 Verva Pharma - Small molecule insulin-based therapies for diabetes. This company is not active anymore. Raised a total funding of $2.11M over 2 rounds from 4 investors.See details»
Verva Pharmaceuticals Ltd. - Drug pipelines, Patents, Clinical trials ...
Explore Verva Pharmaceuticals Ltd. with its drug pipeline, therapeutic area, technology platform, 1 clinical trial, and 4 literature, Drug:VVP-100X, Obesity therapy (Verva Pharmaceuticals).See details»
VersaPharm 2025 Company Profile: Valuation, Investors …
Information on acquisition, funding, investors, and executives for VersaPharm. Use the PitchBook Platform to explore the full profile.See details»
Versa Pharma
Versa PharmaSee details»
VERVA PHARMACEUTICALS - Profile, contacts and insights | The
Find key decision-makers, contacts, emails, headcount, share capital, recent funding, IPO status and other insights of VERVA PHARMACEUTICALS.See details»
Verva Pharmaceuticals Ltd. - BioCentury Company Profiles - BCIQ
Nov 30, 2017 Verva Pharmaceuticals Ltd. - BioCentury Company Profiles for the biopharma industrySee details»
VersaPharm LLC - Company Profile and News - Bloomberg Markets
Company profile page for VersaPharm LLC including stock price, company news, executives, board members, and contact informationSee details»
Verva Pharmaceuticals - VentureRadar
"Verva was formed in December 2007 by the merger of Uniseed investee Adipogen Pharmaceuticals with Autogen Research (the metabolic diseases focused subsidiary of …See details»
VersaPharm Incorporated Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for VersaPharm Incorporated of Marietta, GA. Get the latest business insights from Dun & Bradstreet.See details»
Verva Pharmaceuticals Ltd.:Company Profile & Technical Research ...
Discovery Company profile page for Verva Pharmaceuticals Ltd. including technical research,competitor monitor,market trends,company profile& stock symbolSee details»
Preqin | Alternative Assets Data, Solutions and Insights
Preqin is the alternative assets industry's leading source of data and intelligence, covering private equity, hedge funds, real estate, infrastructure and private debt. With data on fund managers, …See details»
VersaPharm - Crunchbase Company Profile & Funding
VersaPharm is a developer and marketer of generic pharmaceuticals to niche markets within the United States. The Company currently offers a diversified portfolio of generic pharmaceuticals …See details»
Verva Pharmaceuticals - Contacts, Employees, Board Members, …
Verva Pharmaceuticals is a clinical-stage pharmaceutical company.See details»
Verva - Uniseed
Verva was formed in December 2007 by the merger of Uniseed investee Adipogen Pharmaceuticals with Autogen Research (the metabolic diseases focused subsidiary of …See details»
Akorn plans $440M acquisition of VersaPharm - Yahoo Finance
May 9, 2014 Akorn Inc. has announced plans to spend $440 million in cash to buy the parent company of fellow generic drugmaker VersaPharm Inc. less than a month after it polished off …See details»
Verva Pharmaceuticals | VentureRadar
Verva was formed in December 2007 by the merger of Uniseed investee Adipogen Pharmaceuticals with Autogen Research (the metabolic diseases focused subsidiary of …See details»
Akorn to Acquire VersaPharm for $440 Million - drug-dev.com
Akorn, Inc. recently announced it has entered into a definitive agreement to acquire VPI Holdings Corp., the parent company of VersaPharm Incorporated, for $440 million in cash. VersaPharm, …See details»
www.vericapharma.com
Www.vericapharma.comSee details»